Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I

Bokun Cheng, I. Fen Liu, Yuk Ching Tse-Dinh

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives: DNA topoisomerases utilize a covalent complex formed after DNA cleavage as an intermediate in the interconversion of topological forms via DNA cleavage and religation. Many anticancer and antibacterial therapeutic agents are effective because they stabilize or increase the level of the covalent topoisomerase-DNA complex formed by type IIA or type IB topoisomerases. Our goal is to identify small molecules that can enhance DNA cleavage by type IA DNA topoisomerase. Compounds that act in this mechanism against type IA topoisomerase have not been identified previously and could be leads for development of a new class of antibacterial agents. Methods: High throughput screening was carried out to select small molecules that induce the SOS response of Escherichia coli, overexpressing recombinant Yersinia pestis topoisomerase I. The initial hit compounds were further tested for inhibition of bacterial growth and bacterial topoisomerase I activity. Results: Three compounds with antibacterial activity that enhance the cleavage activity of bacterial topoisomerase I were identified. Conclusions: Small molecules that can enhance the DNA cleavage activity of type IA DNA topoisomerase can be identified and may provide leads for development of novel antibacterial compounds.

Original languageEnglish (US)
Pages (from-to)640-645
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Volume59
Issue number4
DOIs
StatePublished - Apr 1 2007
Externally publishedYes

Fingerprint

Bacterial DNA
Type I DNA Topoisomerase
DNA Cleavage
DNA Topoisomerases
High-Throughput Screening Assays
Anti-Bacterial Agents
Yersinia pestis
Escherichia coli
Growth

Keywords

  • Antibiotics
  • High throughput screening
  • Y. pestis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. / Cheng, Bokun; Liu, I. Fen; Tse-Dinh, Yuk Ching.

In: Journal of Antimicrobial Chemotherapy, Vol. 59, No. 4, 01.04.2007, p. 640-645.

Research output: Contribution to journalArticle

@article{fe5174c032b942d088be3db15c028f9e,
title = "Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I",
abstract = "Objectives: DNA topoisomerases utilize a covalent complex formed after DNA cleavage as an intermediate in the interconversion of topological forms via DNA cleavage and religation. Many anticancer and antibacterial therapeutic agents are effective because they stabilize or increase the level of the covalent topoisomerase-DNA complex formed by type IIA or type IB topoisomerases. Our goal is to identify small molecules that can enhance DNA cleavage by type IA DNA topoisomerase. Compounds that act in this mechanism against type IA topoisomerase have not been identified previously and could be leads for development of a new class of antibacterial agents. Methods: High throughput screening was carried out to select small molecules that induce the SOS response of Escherichia coli, overexpressing recombinant Yersinia pestis topoisomerase I. The initial hit compounds were further tested for inhibition of bacterial growth and bacterial topoisomerase I activity. Results: Three compounds with antibacterial activity that enhance the cleavage activity of bacterial topoisomerase I were identified. Conclusions: Small molecules that can enhance the DNA cleavage activity of type IA DNA topoisomerase can be identified and may provide leads for development of novel antibacterial compounds.",
keywords = "Antibiotics, High throughput screening, Y. pestis",
author = "Bokun Cheng and Liu, {I. Fen} and Tse-Dinh, {Yuk Ching}",
year = "2007",
month = "4",
day = "1",
doi = "10.1093/jac/dkl556",
language = "English (US)",
volume = "59",
pages = "640--645",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I

AU - Cheng, Bokun

AU - Liu, I. Fen

AU - Tse-Dinh, Yuk Ching

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Objectives: DNA topoisomerases utilize a covalent complex formed after DNA cleavage as an intermediate in the interconversion of topological forms via DNA cleavage and religation. Many anticancer and antibacterial therapeutic agents are effective because they stabilize or increase the level of the covalent topoisomerase-DNA complex formed by type IIA or type IB topoisomerases. Our goal is to identify small molecules that can enhance DNA cleavage by type IA DNA topoisomerase. Compounds that act in this mechanism against type IA topoisomerase have not been identified previously and could be leads for development of a new class of antibacterial agents. Methods: High throughput screening was carried out to select small molecules that induce the SOS response of Escherichia coli, overexpressing recombinant Yersinia pestis topoisomerase I. The initial hit compounds were further tested for inhibition of bacterial growth and bacterial topoisomerase I activity. Results: Three compounds with antibacterial activity that enhance the cleavage activity of bacterial topoisomerase I were identified. Conclusions: Small molecules that can enhance the DNA cleavage activity of type IA DNA topoisomerase can be identified and may provide leads for development of novel antibacterial compounds.

AB - Objectives: DNA topoisomerases utilize a covalent complex formed after DNA cleavage as an intermediate in the interconversion of topological forms via DNA cleavage and religation. Many anticancer and antibacterial therapeutic agents are effective because they stabilize or increase the level of the covalent topoisomerase-DNA complex formed by type IIA or type IB topoisomerases. Our goal is to identify small molecules that can enhance DNA cleavage by type IA DNA topoisomerase. Compounds that act in this mechanism against type IA topoisomerase have not been identified previously and could be leads for development of a new class of antibacterial agents. Methods: High throughput screening was carried out to select small molecules that induce the SOS response of Escherichia coli, overexpressing recombinant Yersinia pestis topoisomerase I. The initial hit compounds were further tested for inhibition of bacterial growth and bacterial topoisomerase I activity. Results: Three compounds with antibacterial activity that enhance the cleavage activity of bacterial topoisomerase I were identified. Conclusions: Small molecules that can enhance the DNA cleavage activity of type IA DNA topoisomerase can be identified and may provide leads for development of novel antibacterial compounds.

KW - Antibiotics

KW - High throughput screening

KW - Y. pestis

UR - http://www.scopus.com/inward/record.url?scp=34250015066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250015066&partnerID=8YFLogxK

U2 - 10.1093/jac/dkl556

DO - 10.1093/jac/dkl556

M3 - Article

C2 - 17317696

AN - SCOPUS:34250015066

VL - 59

SP - 640

EP - 645

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 4

ER -